The global coronary heart disease diagnostic imaging market size was estimated at USD 4.67 billion in 2025 and is projected to reach USD 7.73 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. Growth is driven by the rising prevalence of cardiovascular diseases, increasing adoption of advanced imaging technologies such as CT, MRI, and nuclear imaging, and growing awareness of early diagnosis.
In addition, aging populations and lifestyle-related risk factors are fueling demand for accurate and non-invasive diagnostic solutions. Technological advancements, including AI integration and improved imaging accuracy, are further supporting market expansion, enabling better clinical outcomes and enhancing the efficiency of cardiovascular disease management worldwide.
One of the main factors driving the market expansion for coronary heart disease diagnostic imaging devices is the rising incidence of coronary artery diseases (CAD) worldwide. With nearly 19.8 million deaths per year, cardiovascular diseases continue to be the leading cause of death globally, with coronary heart disease accounting for a sizable portion of these deaths. Coronary artery disease (CAD) is primarily caused by atherosclerosis, which leads to the narrowing or blockage of coronary arteries. The demand for diagnostic imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, and coronary angiography have directly increased due to the increasing number of patients at risk.
Moreover, demographic changes, especially population aging, have led to a marked increase in the prevalence of CAD. The incidence of coronary conditions is higher in older populations because they are more vulnerable to atherosclerotic changes. For instance, compared to younger populations, prevalence rates are significantly higher among those over 65, underscoring age as a crucial risk factor. Furthermore, a greater number of patients have chronic cardiovascular conditions because of longer life expectancies worldwide, which has increased the use of diagnostic imaging technologies over time.
This product will be delivered within 1-3 business days.
In addition, aging populations and lifestyle-related risk factors are fueling demand for accurate and non-invasive diagnostic solutions. Technological advancements, including AI integration and improved imaging accuracy, are further supporting market expansion, enabling better clinical outcomes and enhancing the efficiency of cardiovascular disease management worldwide.
One of the main factors driving the market expansion for coronary heart disease diagnostic imaging devices is the rising incidence of coronary artery diseases (CAD) worldwide. With nearly 19.8 million deaths per year, cardiovascular diseases continue to be the leading cause of death globally, with coronary heart disease accounting for a sizable portion of these deaths. Coronary artery disease (CAD) is primarily caused by atherosclerosis, which leads to the narrowing or blockage of coronary arteries. The demand for diagnostic imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, and coronary angiography have directly increased due to the increasing number of patients at risk.
Moreover, demographic changes, especially population aging, have led to a marked increase in the prevalence of CAD. The incidence of coronary conditions is higher in older populations because they are more vulnerable to atherosclerotic changes. For instance, compared to younger populations, prevalence rates are significantly higher among those over 65, underscoring age as a crucial risk factor. Furthermore, a greater number of patients have chronic cardiovascular conditions because of longer life expectancies worldwide, which has increased the use of diagnostic imaging technologies over time.
Global Coronary Heart Disease Diagnostic Imaging Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global coronary heart disease diagnostic imaging market report based on modality and region:Modality Outlook (Revenue, USD Million, 2021-2033)
- Computed Tomography
- X rays
- Ultrasound
- Magnetic Resonance Imaging
- Nuclear Medicine
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Global Coronary Heart Disease Diagnostic Imaging Market Variables, Trends & Scope
Chapter 4. Coronary Heart Disease Diagnostic Imaging Market: Modality Estimates & Trend Analysis
Chapter 5. Coronary Heart Disease Diagnostic Imaging Market: Regional Estimates & Trend Analysis by Country, Application, and End-use
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- GE Healthcare
- Koninklijke Philips
- Siemens Healthineers AG
- Fujifilm Sonosite, Inc.
- Canon Medical Systems Corporation
- Samsung Medison Co. Ltd
- Shimadzu Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- Arineta Ltd
- Esaote SpA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 4.67 Billion |
| Forecasted Market Value ( USD | $ 7.73 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
